High-Density Lipoprotein and the Risk of Recurrent Venous Thromboembolism
- 27 March 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 115 (12) , 1609-1614
Abstract
Background— High-density lipoprotein (HDL) protects against arterial atherothrombosis, but it is unknown whether it protects against recurrent venous thromboembolism. Methods and Results— We studied 772 patients after a first spontaneous venous thromboembolism (average follow-up 48 months) and recorded the end point of symptomatic recurrent venous thromboembolism, which developed in 100 of the 772 patients. The relationship between plasma lipoprotein parameters and recurrence was evaluated. Plasma apolipoproteins AI and B were measured by immunoassays for all subjects. Compared with those without recurrence, patients with recurrence had lower mean (±SD) levels of apolipoprotein AI (1.12±0.22 versus 1.23±0.27 mg/mL, P Conclusions— Patients with high levels of apolipoprotein AI and HDL have a decreased risk of recurrent venous thromboembolism.Keywords
This publication has 27 references indexed in Scilit:
- The effects of statins on high-density lipoproteinsCurrent Atherosclerosis Reports, 2006
- Low HDL Cholesterol LevelsNew England Journal of Medicine, 2005
- Deep vein thrombosisThe Lancet, 2005
- The Risk of Recurrent Venous Thromboembolism in Men and WomenNew England Journal of Medicine, 2004
- Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL CholesterolNew England Journal of Medicine, 2004
- An Association between Atherosclerosis and Venous ThrombosisNew England Journal of Medicine, 2003
- Plasma Lipoproteins, Hemostasis and ThrombosisThrombosis and Haemostasis, 2001
- Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolismBlood, 2000
- Risk of Fatal Pulmonary Embolism in Patients With Treated Venous ThromboembolismJAMA, 1998
- HYPERCHOLESTEROLEMIA AS A RISK FACTOR FOR DEEP-VEIN THROMBOSISThrombosis Research, 1997